Related Experiment Videos
Enhancement of morphine analgesia and brain levels by methamphetamine in mice
Abstract:
Methamphetamine and morphine were approximately equipotent in producing analgesia in mice using the tail-flick assay. The ED50 for morphine analgesia was significantly reduced when 3.2 mg/kg of methamphetamine was given 5 or 60 min before morphine. Methamphetamine pretreatment increased the peak effect but did not alter the duration of morphine analgesia. Enhancement of morphine analgesia was apparent when methamphetamine was given up to 60 min before morphine and it did not coincide with analgesia produced by methamphetamine alone. Brain levels of morphine were found to be significantly higher in methamphetamine- compared to saline-pretreated mice, at times when enhanced analgesia was observed. Further studies showed that morphine brain levels were increased by methamphetamine pretreatment in an apparent dose-dependent manner. The analgesia observed at several morphine brain levels was compared in order to determine whether enhanced analgesia resulted from increased morphine brain levels. Methamphetamine administration 5 or 60 min before morphine shifted the log morphine brain level-response curves for morphine analgesia to the left and the morphine brain level at a given percent analgesia was significantly lower in methamphetamine- than in saline-pretreated mice. In addition, methamphetamine pretreatment enhanced methadone analgesia but had no effect on methadone brain levels.
Insights
Methamphetamine enhances morphine analgesia by increasing its levels in the brain, but does not affect the duration of pain relief. This interaction boosts the pain-killing effects of morphine.
Area of Science:
- Neuroscience
- Pharmacology
- Toxicology
Background:
- Opioids like morphine are primary analgesics.
- Methamphetamine is a stimulant with some analgesic properties.
- Understanding drug interactions is crucial for pain management and harm reduction.
Purpose of the Study:
- To investigate the effect of methamphetamine pretreatment on morphine-induced analgesia.
- To determine if methamphetamine alters morphine's pharmacokinetic or pharmacodynamic properties.
- To explore the relationship between brain drug levels and analgesic effects.
Main Methods:
- Utilized the tail-flick assay in mice to measure analgesia.
- Administered methamphetamine at specific doses and time points before morphine.
- Measured brain concentrations of morphine and methadone.
- Analyzed dose-response curves for morphine and methadone analgesia.
Main Results:
- Methamphetamine pretreatment significantly enhanced morphine analgesia, reducing the effective dose (ED50).
- Enhanced analgesia correlated with increased brain levels of morphine, suggesting a pharmacokinetic interaction.
- Methamphetamine also enhanced methadone analgesia without altering its brain levels.
- The duration of morphine analgesia was not affected by methamphetamine.
Conclusions:
- Methamphetamine potentiates opioid analgesia, likely by increasing central opioid bioavailability.
- This interaction may have implications for opioid use and overdose risk.
- The mechanism appears to involve altered drug distribution rather than changes in receptor sensitivity.